Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients?
- PMID: 32962148
- PMCID: PMC7565862
- DOI: 10.3390/vaccines8030544
Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients?
Abstract
COVID-19 might potentially give rise to a more severe infection in solid organ transplant recipients due to their chronic immunosuppression. These patients are at a higher risk of developing concurrent or secondary bacterial and fungal infections. Co-infections can increase systemic inflammation influencing the prognosis and the severity of the disease, and can in turn lead to an increased need of mechanical ventilation, antibiotic therapy and to a higher mortality. Here we describe, for the first time in Europe, a fatal case of co-infection between SARS-CoV-2 and Pneumocystis jirevocii in a kidney transplant recipient.
Keywords: COVID-19; immunosuppression; pneumonia.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- ECDC . Coronavirus Disease 2019 (COVID-19) in the EU/EEA and the UK—Eleventh Update. ECDC; Stockholm, Sweden: 2020.
-
- De Wilde A.H., Snijder E.J., Kikkert M., van Hemert M.J. Host Factors in Coronavirus Replication. In: Tripp R.A., Tompkins S.M., editors. Roles of Host Gene and Non-Coding RNA Expression in Virus Infection. Springer International Publishing; Berlin/Heidelberg, Germany: 2018. pp. 1–42. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
